TEVA 📈 Teva Pharma Industries Ltd - Overview

Teva Pharmaceutical Industries Limited is a global leader in the development, manufacture, and distribution of a wide range of pharmaceutical products, including generic medicines, specialty medicines, and biopharmaceuticals. With operations in North America, Europe, Israel, and internationally, the company offers a diverse portfolio of products that cater to various therapeutic areas, such as the central nervous system, respiratory, and oncology. Its product lineup includes tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams, as well as sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms.

The company's focus on the central nervous system, respiratory, and oncology areas is reflected in its range of specialty medicines, including BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma, GRANIX, TRISENOX, LONQUEX, and TEVAGRASTIM/RATIOGRASTIM. Additionally, Teva offers COPAXONE for the treatment of relapsing forms of multiple sclerosis, AJOVY for the preventive treatment of migraine in adults, AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia, and UZEDY for the treatment of schizophrenia. Its respiratory portfolio includes ProAir RespiClick inhalation powder, QVAR for treatment for asthma, BRALTUS, a long-acting muscarinic antagonist, CINQAIR/CINQAERO injection, DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator, and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder.

Teva also has a significant presence in the over-the-counter (OTC) market, offering a range of products under brand names such as SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA. The company's active pharmaceutical ingredients and contract manufacturing services are also in high demand, and its out-licensing platform provides a portfolio of products to other pharmaceutical companies. With collaboration agreements with major players such as MedinCell, Sanofi, Alvotech, and Biolojic Design Ltd., as well as a license agreement with MODAG GmbH, Teva is well-positioned to drive innovation and growth in the pharmaceutical industry. Founded in 1901 and headquartered in Tel Aviv, Israel, Teva Pharmaceutical Industries Limited is a common stock company listed on the NYSE under the ticker symbol TEVA, with a GICS Sub Industry classification of Pharmaceuticals.